Skip to main content

Grafa News and Videos — Page 1095

Grafa Headlines

Latest

Grafa

Edesa Biotech reports positive exploratory data for paridiprubart in acute kidney injury

Edesa Biotech (NASDAQ:EDSA) announced favorable exploratory findings for its lead therapeutic candidate, paridiprubart, in patients suffering from acute kidney injury (AKI) and concurrent respiratory distress.

Read more: Edesa Biotech reports positive exploratory data for paridiprubart in acute kidney injury

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift